US Supreme Court On Friday, Judge Samuel Alito stepped in to temporarily block a lower court decision imposing restrictions on mifepristone, a pill used for medical abortion. The action essentially suspends a Texas judge’s ruling last week that nullified the drug’s approval by the Food and Drug Administration. It also nullifies an attempt by the Fifth Circuit Court of Appeals late Wednesday to limit access to the drug.
This means that the use of mifepristone is still legal and can be distributed and received by mail until the tenth week of pregnancy, at least until midnight on Wednesday, April 19, when the moratorium ends. increase.
The Justice Department has appealed the Fifth Circuit Court’s ruling, and the Supreme Court has ordered all parties to submit their responses by noon on Tuesday, April 18.
The case for mifepristone came to an end on April 7, when Judge Matthew Kaksmalik of the Northern District of Texas ruled to overturn decades of scientific consensus about the safety of mifepristone and cancel its FDA approval. A legal frenzy erupted. Kacsmaryk’s ruling argued that the pill was unsafe and that the FDA hadn’t taken enough care in approving it in 2000. This is the first and most significant court decision to remove a long-approved drug from the market.On reproductive rights since the Supreme Court overturned Law vs Wade.
On the same day as Kacsmaryk’s ruling, a Washington judge issued a conflicting order, saying the FDA must keep mifepristone available in 17 states and the District of Columbia.
Mifepristone has been marketed in France since 1988 and was approved in 2000 after careful consideration of its safety and efficacy by the FDA. It is also approved in the UK, Sweden, and dozens of other countries. The first tablet in a two-step regimen that blocks the hormone progesterone needed for pregnancy. Her second medication, misoprostol, is taken 24 to 48 hours after her on mifepristone to complete the abortion. The 2-tablet combination can be used until her first 10 weeks of pregnancy. As of 2020, medical abortions accounted for just over half of all abortions in the United States.
Late Wednesday, a federal appeals court partially blocked Kacsmaryk’s order, keeping mifepristone on the market but imposing certain key restrictions on its access. The ruling, issued by the court, bans mail-in dispensation of pills and shortens the period during which pills can be obtained from 10 weeks to seven weeks. These new restrictions roll back changes the FDA has made in recent years to expand the availability of the pill, especially during a pandemic that has made telemedicine necessary for some patients.
U.S. Attorney General Merrick Garland said on Thursday, April 13, that the Department of Justice has “urgently called upon the Supreme Court to defend the FDA’s scientific judgment and protect Americans’ access to safe and effective reproductive medicine.” asked for relief,” he said. The ministry appealed to the Supreme Court on Friday morning.
Legal experts and industry insiders believe that the courts’ interference with the FDA’s authority could prevent other drugs, especially those deemed politically sensitive, such as hormonal contraceptives, HIV prophylaxis, and even vaccines. I am concerned that access to the may be compromised.
